secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-08-29T23:59:59+00:00
Accession:  0001005286-24-000128
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore appoints Ryan Lake as CFO effective Sept 3; Morberg departs Sept 2
---------------------------------------------------------------------------

- John Morberg steps down as CFO effective Sept 2, 2024; Ryan Lake succeeds him on Sept 3, 2024.
- Lake receives $470K base salary, RSU for 262,500 shares, and PSU for up to 750,000 shares under Inducement Plan.
- Lake previously served as CFO of Societal CDMO, leading its sale to CoreRx in April 2024.
- Morberg's separation treated as termination without Cause after a Change in Control under his employment agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000128/0001005286-24-000128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000128/lndc-20240828.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer